• 23 September 2016
  • Interviews
  • By Srinivas

“Biotech has a unique advantage of contributing immensely to all sectors”

Recently BioSpectrum team met Dr. Renu Swarup in her office to discuss various funding aspects of BIRAC and Startup trends in India

dr-renu-swarup

Dr. Renu Swarup is presently Senior Adviser to the Department of Biotechnology (DBT). At DBT, she heads the National Bioresource Development Board and is involved in developing, funding and monitoring programmes in the area of Energy Biosciences, Bio resource Development and Utilization and Plant Biotechnology - Bio prospecting, Tissue Culture and other Biomass associated programmes. As a Science Manager, issues related to policy planning and implementation are also a part of her assignment. She was actively engaged in formulation of the Biotechnology Vision in 2001 and National Biotechnology Development Strategy in 2007 as the Member Secretary of the Expert Committee. She was also a member of the Task Force on Women in Science constituted by the Scientific Advisory Committee to the Prime Minister. She was awarded the "Bio Spectrum Person of the Year Award" in 2012.

Recently BioSpectrum team met her in her office to discuss various funding aspects of BIRAC and Startup trends in India: Excerpts:

What are the startup trends in the recent times?

Startup ecosystem is growing and DBT and BIRAC is nurturing it from past four years. Now with the Prime Minister announcing 'Startup India and Stand Up India' program, we are giving it more importance. Today over 500-600 startups are supported through BIRAC and the trend is increasing. Sectorially, I would say focus is more on healthcare - within healthcare more on medical devices and diagnostics. The reason for that is obviously less complex regulation and huge market place. Also infrastructure and Capex requirement to set up initially is not complex. But having said that more and more people are moving towards discovery research startups. Agriculture and industrial process is also slowly picking up.

How is BIRAC positioning itself so as to contribute to DBT's Mission $100 billion by 2025?

Previous 1 3 4 5 6 7 Next

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

GST

GST: Boon or Bane for Healthcare?

Send this article by email

X